Patient With Locally Advanced Prostate Cancer

Treatments intended to reduce biochemical recurrence in patients with prostate cancer may not improve long-term survival, recent research showed.

In this episode of the “CURE® Talks Cancer” podcast, Leanne Burnham, Ph.D., discusses the research she’s working on to address health disparities in Black men with prostate cancer after being inspired by her father’s diagnosis, and shares her own cancer survival story.

Here’s a look back at the therapies for solid cancers that gained FDA approval this summer.

On this week’s episode of the CURE Talks Cancer podcast, we talk with Grammy-winning songwriter and vocal producer Kuk Harrell about what it’s like to be “on the other side” of his prostate cancer diagnosis, and how he’s using his platform to shine a light on the disease.

When asked for recommended treatments for certain types of cancer, ChatGPT missed the mark about one-third of the time, research showed.

Treatment with Cabometyx plus Tecentriq improved progression-free survival for patients with metastatic castration-resistant prostate cancer.